CNY man first in U.S. to get newly expanded treatment for advanced prostate cancer

[madman]

Dr. Steven Finkelstein

On July 31, 2026, the FDA approved Pluvicto combined with androgen deprivation therapy and an androgen receptor pathway inhibitor, specifically for patients with positive metastatic hormone-sensitive prostate cancer.

 

[madman]

Thread 'Prostate Cancer Awareness'

Oct 9, 2023

Prostate Cancer Awareness

www.wjhg.com

• madman
• Diagnosis/treatment men's health prostate cancer
• Replies: 3
• Forum: Prostate Related Issues